Home > M&A deals 2006 > Glaxosmithkline plc acquires CNS, Inc.
Add-on Acquistion · Life Science · October 2006

Glaxosmithkline plc acquires CNS, Inc.

On October 9, 2006, Glaxosmithkline plc acquired CNS, Inc., a life science company in Minnesota, United States.

Deal at a glance

AnnouncedOctober 9, 2006 TypeAdd-on Acquistion TargetCNS, Inc. Buyer Glaxosmithkline plc SectorLife Science LocationMinnesota, United States ValueMembers only

Target company

CNS, Inc.
Minnesota, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Glaxosmithkline plc
Company · 84 deals on record
  • 6th transaction in life science
  • 8th transaction in United States
84deals, all time
57in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Affinivax, Inc.Same lead buyer · May 2022
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired CNS, Inc.?Glaxosmithkline plc acquired CNS, Inc. on October 9, 2006.

What type of deal was it?It was a add-on acquistion in the life science sector in 2006.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).